Experienced in Palmoplantar Keratoderma

Jasper J. Van Der Smagt-Van Der Lugt

Utrecht, UT, NL 
Experienced in Palmoplantar Keratoderma
Utrecht, UT, NL 
OverviewLocationsClinical Research

Overview

Jasper Van Der Smagt-Van Der Lugt practices in Utrecht, Netherlands. Mr. Van Der Smagt-Van Der Lugt is rated as an Experienced expert by MediFind in the treatment of Palmoplantar Keratoderma. His top areas of expertise are Glioma, Gliomatosis Cerebri, Ventricular Fibrillation, Cardiomyopathy, and Thrombectomy.

His clinical research consists of co-authoring 117 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Palmoplantar Keratoderma.

Gender
Male

Locations

Utrecht, UT, Netherlands
Other Locations
St Antonius Hospital, Nieuwegein, UT, Netherlands
Rotterdam, ZH, Netherlands
Breda, NB, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 1
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma
Enrollment Status: Terminated
Publish Date: May 31, 2022
Intervention Type: Drug
Study Drugs: Vinblastine+Nilotinib, Vinblastine
Study Phase: Phase 2
Traumatic Splenic Injury and Management (SPLENIQ Study) Quality of Life and Clinical Outcomes of Treatment for Splenic Injury After Trauma
Traumatic Splenic Injury and Management (SPLENIQ Study) Quality of Life and Clinical Outcomes of Treatment for Splenic Injury After Trauma
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Diagnostic test, Other
View 2 Less Clinical Trials

117 Total Publications

Profiling the immune tumor microenvironment of pediatric brain tumors with cavitron ultrasonic surgical aspirator (CUSA)-derived tissue fragments.
Profiling the immune tumor microenvironment of pediatric brain tumors with cavitron ultrasonic surgical aspirator (CUSA)-derived tissue fragments.
Journal: Neuro-oncology advances
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Der Smagt-Van Der Lugt's expertise for a condition
ConditionClose
      View All 51 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile